News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AltheRx Pharmaceuticals Appoints Michael R Dougherty to Board of Directors



5/30/2013 7:14:14 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the appointment of Michael R Dougherty, former President and CEO of Adolor Corporation, to its Board of Directors. Effective immediately, Michael joins recently appointed board members Anthony Zook, former President and CEO of AstraZeneca North America, and Jeffrey O’Donnell, Managing Director of BioStar Ventures.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES